New hope in the treatment of arthritis

World largest genetic study of osteoarthritis provide new approaches to treatment In the world’s largest genetic study of osteoarthritis changes in the genome have been discovered, which are associated with the disease. In addition, the researchers found approaches to partially existing medications for osteoarthritis. Approximately five million Germans are affected by the disease Osteoarthritis is the most widespread musculoskeletal disease […]

Read more

Joint mobilization plus exercise beneficial for knee osteoarthritis

(HealthDay)—Patellar mobilization therapy (PMT) plus exercise has the potential to reduce pain and improve function and quality of life for patients with knee osteoarthritis, according to a phase 2 study published Nov. 12 in the Annals of Family Medicine. Regina Wing Shan Sit, M.B.B.S., from the Chinese University of Hong Kong, and colleagues randomly assigned 208 primary care patients with […]

Read more

Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients

NEW YORK & INDIANAPOLIS–(BUSINESS WIRE October 23, 2018 )–Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced complete results from a Phase 3 study evaluating the efficacy and safety of subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, in patients with osteoarthritis (OA) pain treated for 16 weeks. The study met all three co-primary efficacy endpoints, demonstrating […]

Read more